Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on BCRX. BioCryst Pharmaceuticals, Inc.'s share was trading at $9.30 as of March 16th. BCRX’s trailing and forward P/E were 7.69 and 109.89 respectively according to Yahoo Finance. Eli Lilly and Company (LLY) Gains as Medicare Expansion of GLP-1 Weight Loss Drugs Eases Pricing Concerns Copyright: zneb076 / 123RF Stock Photo BioCryst ...